seed
Stage
2
Investors
About
Vactech develops preventive vaccines and diagnostic technologies targeting type 1 diabetes, celiac disease, and enterovirus infections, advancing clinical trials for their lead vaccine PRV-101.
Explore Vactech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.